2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide

C18H18N2O2 — CID 108505624

IUPAC2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide
SMILESCN(C(=O)C(=O)N1CCCc2ccccc21)c1ccccc1
InChIInChI=1S/C18H18N2O2/c1-19(15-10-3-2-4-11-15)17(21)18(22)20-13-7-9-14-8-5-6-12-16(14)20/h2-6,8,10-12H,7,9,13H2,1H3
InChIKeyRXZZMCHBUWVSEJ-UHFFFAOYSA-N
MW294.35 g/mol
LogP2.63
Rot. Bonds1

About 2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide

2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide (PubChem CID 108505624) has the molecular formula C18H18N2O2 and a molecular weight of 294.35 g/mol. Its IUPAC name is 2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide.

Molecular Properties

Compound Name2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide
PubChem CID108505624
Molecular FormulaC18H18N2O2
Molecular Weight294.35 g/mol
Exact Mass294.14
IUPAC Name2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide
SMILESCN(C(=O)C(=O)N1CCCc2ccccc21)c1ccccc1
InChIInChI=1S/C18H18N2O2/c1-19(15-10-3-2-4-11-15)17(21)18(22)20-13-7-9-14-8-5-6-12-16(14)20/h2-6,8,10-12H,7,9,13H2,1H3
InChIKeyRXZZMCHBUWVSEJ-UHFFFAOYSA-N
XLogP2.63
TPSA40.62 Ų
H-Bond Donors
H-Bond Acceptors2
Rotatable Bonds1
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500294.35
LogP ≤ 52.63
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze 2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(2,3-dihydroindol-1-yl)-N-methyl-2-oxo-N-phenylacetamide
CID 108521001
N-acetyl-N-(3-aminophenyl)-2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoacetamide
CID 108505664
2-(3,4-dihydro-2H-quinolin-1-yl)-N-[3-(dimethylamino)phenyl]-2-oxoacetamide
CID 108505690
4-[[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethyl]amino]-N-methyl-N-phenylbenzamide
CID 54838496
1-(3,4-dihydro-2H-quinolin-1-yl)ethanone;ethane
CID 143423489
4-[3,4-dihydro-2H-quinoline-1-carbonyl(methyl)amino]butanoic acid
CID 43329794
2,3-dimethyl-4-oxo-4-(2,3,4,5-tetrahydro-1-benzazepin-1-yl)but-2-enoic acid
CID 77069929
2-(3,4-dihydro-1H-isoquinolin-2-yl)-N-methyl-2-oxo-N-phenylacetamide
CID 3453763
3-(2,3-dihydroindol-1-yl)-N-methyl-3-oxo-N-phenylpropanamide
CID 108953153
3-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-3-oxo-N-phenylpropane-1-sulfonamide
CID 110342965
2,3,4,5-tetrahydro-1-benzazepine-1-carboxylic acid
CID 90953923
1-(4-acetylpiperazin-1-yl)-3-(3,4-dihydro-2H-quinolin-1-yl)-2,2-dimethylpropane-1,3-dione
CID 108961236

Frequently Asked Questions

What is the IUPAC name of 2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide?
The IUPAC name of 2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide (CID 108505624) is 2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide.
What is the SMILES notation for 2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide?
The canonical SMILES for 2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide is CN(C(=O)C(=O)N1CCCc2ccccc21)c1ccccc1.
What is the InChIKey of 2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide?
The InChIKey is RXZZMCHBUWVSEJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H18N2O2/c1-19(15-10-3-2-4-11-15)17(21)18(22)20-13-7-9-14-8-5-6-12-16(14)20/h2-6,8,10-12H,7,9,13H2,1H3.
What are the key properties of 2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide?
2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide has a molecular weight of 294.35 g/mol, XLogP of 2.63, 1 rotatable bonds, 0 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(3,4-dihydro-2H-quinolin-1-yl)-N-methyl-2-oxo-N-phenylacetamide is sourced from PubChem (CID 108505624), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).